Does Neutron Radiation Therapy Potentiate an Immune Response to Merkel Cell Carcinoma?

BACKGROUND: Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous malignancy. In the advanced setting, MCC is often treated with immune checkpoint inhibitors such as anti-PD-1/PD-L1 antibodies. X-ray radiation therapy (XRT) is commonly used for palliation. There is an unmet need for new tre...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Part Ther
Asıl Yazarlar: Schaub, Stephanie K., Stewart, Robert D., Sandison, George A., Arbuckle, Thomas, Liao, Jay J., Laramore, George E., Zeng, Jing, Rengan, Ramesh, Tseng, Yolanda D., Mayr, Nina A., Bhatia, Shailender, Nghiem, Paul T., Parvathaneni, Upendra
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The Particle Therapy Co-operative Group 2018
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6871593/
https://ncbi.nlm.nih.gov/pubmed/31773029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14338/IJPT-18-00012.1
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller